Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
AU StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

959.609
+14.5921.54%
Number of Gainers:9
Number of Losers:6
Number of Flat:18
PE:- -
High:961.366
Open:944.384
Low:944.384
Close:945.017
Volume:8.69M
Turnover:92.88M
Market Cap:235.98B
Float Cap:194.04B

Loading ...

OverviewNews

Cynata Therapeutics - no Dividends Declared for Fy2026

THOMSON REUTERS
·
Aug 31

Cynata Therapeutics - Fy2026 Loss from Ordinary Activities After Tax A$9.1 Mln

THOMSON REUTERS
·
Aug 31

Anteotech Ltd - FY Revenues from Ordinary Activities A$467,589

THOMSON REUTERS
·
Aug 31

Anteotech Ltd - Loss for Year Attributable A$4.9 Mln

THOMSON REUTERS
·
Aug 31

Genetic Signatures Ltd-Board Changes

THOMSON REUTERS
·
Aug 31

Genetic Signatures - Caroline Waldron Resigns as Non-Executive Chair and Director Effective Today

THOMSON REUTERS
·
Aug 31

Genetic Signatures - Mike Aicher Assumes Role of Chair at Genetic Signatures

THOMSON REUTERS
·
Aug 31

ASX Growth Companies With High Insider Ownership In August 2026

Simply Wall St.
·
Aug 31

CSL’s latest result suggests the worst may be over

Morning Star AU
·
Aug 31

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.